Skip to content
Catalyst

knowcompoundsacrylamide

Specimen compound organic compoundPlate I

Acrylamide

Nested hairline contours trace the electron density of one computed shape of acrylamide, teal at the edge warming to amber over the atoms.
fig. 1Acrylamide · electron density · PubChem CID 6579, computed 3D conformer
Formula
C3H5NO
Molar mass
71.079 g/mol
PubChem CID
6579
InChIKey
HRPVXLWXLXDGHG-UHFFFAOYSA-N

↓ lowered 1 finding · – no difference found

01 · the evidence, ordered

What the evidence says

Moderate
2
Very limited
1

How to read these marks

Fig. 2 Acrylamide CHEBI:28619 3 endpoints 3 findings
×1.60
Labels
CompoundInspector

Acrylamide

19 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

02 · findings

What acrylamide moved, and by how much

  • SMD standardised mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
  1. Pancreatic cancer incidenceMoved: no difference foundEvidence: ModeratePaper: PMID 332664872020
    Who
    89,729 Japanese men and women aged 45-74 years without prior cancer (JPHC Study), energy-adjusted dietary acrylamide intake by quartile, mean follow-up 15.2 years; whole-cohort result
    Dose studied
    not reported

    We observed no association between dietary acrylamide intake and pancreatic cancer (Table 2).”

    Quoted verbatim from Dietary Acrylamide Intake and the Risk of Pancreatic Cancer: The Japan Public Health Center-Based Prospective Study.cohortPermalink
  2. Type 2 diabetes incidenceMoved: no difference foundEvidence: ModeratePaper: PMID 372178002023
    Who
    6022 adults (2707 men, 3315 women) free of diabetes at baseline in the Tehran Lipid and Glucose Study, dietary acrylamide intake by quartile, median follow-up 6.63 years; whole-cohort result
    Dose studied
    not reported

    Acrylamide intake was positively associated with the incidence of T2D in model 1 (P for trend = 0.009); however, our results showed no association in model 2 after adjusting for confounding variables.”

    Quoted verbatim from The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.cohortPermalink
  3. Birth weightMoved: lowersEffect, as reportedSMD−0.05[−0.09 to −0.02]Evidence: Very limitedPaper: PMID 323498552020
    Who
    Offspring of mothers with high versus low gestational dietary acrylamide exposure; pooled five cohort studies (observational)
    Dose studied
    not reported

    Offspring's birth weight was significantly lower in high AA exposure group than in low AA exposure group (SMD -0·05, 95 % CI -0·09, -0·02, P = 0·005).”

    Quoted verbatim from Relationship between gestational acrylamide exposure and offspring's growth: a systematic review and meta-analysis of cohort studies.meta-analysisPermalink

No dose is advised.

  • SMD standardised mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

03 · identity

Structure

fig. 3Acrylamide · 2D structure · ChEBI’s SMILES
Charge
0
SMILES
C=CC(N)=O

04 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reactions · Rhea
2reactions

05 · the record

Sources

129

papers screened for acrylamide

admitted
3
read and discarded
21
not read yet
105

The screening record, every paper and why

Sources cited

3 papers · 3 findings

Show every paper citedHide the papers cited